“ Cannabidiol ( CBD), 600 mg/day orally for 5 to 12 days, inhibited hexobarbital metabolism in ten subjects.”
“In four subjects who received intravenous and oral hexobarbital , systemic clearance was 36% lower while bioavailability was 10% greater during CBD.”